韩国住院COVID-19患者淋巴细胞亚群计数根据疾病严重程度和SARS-CoV-2变异株的差异

Difference in Lymphocyte Subset Counts According to Disease Severity and SARS-CoV-2 Variants of Hospitalized COVID-19 Patients in Korea.

作者信息

Lee Heayeon, Lee Bora, Kim Sei Won, Yeo Chang Dong, Lee Sang Haak, Lim Jihyang

机构信息

Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Department of Laboratory Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

J Korean Med Sci. 2025 Jul 28;40(29):e172. doi: 10.3346/jkms.2025.40.e172.

Abstract

BACKGROUND

The studies about the characteristics of immune systems and lymphocyte subset counts regarding coronavirus disease 2019 (COVID-19) have been conducted in a number of ways, however studies on the difference of lymphocyte subset counts according to each severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant are rare. As each country has a different quarantine system, it is necessary to investigate the characteristics in places such as South Korea where the vaccination rate is high and a thorough national quarantine system is being operated. The aim of this study was to investigate the difference in peripheral blood lymphocyte subset counts in COVID-19 patients in South Korea according to their disease severity and SARS-CoV-2 variants.

METHODS

A total of 148 hospitalized COVID-19 patients enrolled in this study at Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea. SARS-CoV-2 infection was confirmed using real-time quantitative polymerase chain reaction and COVID-19 severity was divided into three groups (mild, moderate, and severe) at the time of admission, according to the treatment types of oxygen support. Laboratory tests were performed for evaluation of inflammatory status. The peripheral lymphocyte subset counts were analyzed using flow cytometry at the time of admission in all 148 patients and after treatment in 65 patients with moderate or severe severity. We analyzed the changes of peripheral lymphocyte subset counts according to three COVID-19 severity groups and three SARS-CoV-2 variants (wild and alpha, delta and omicron variants).

RESULTS

At admission, total T, CD4+ T, CD8+ T, natural killer (NK), and NKT cell counts decreased, but B cells did not change significantly depending on severity. There were markedly decreased in total T, CD4+ T, CD8+ T, and NK cells in the delta and omicron variants and not in the wild and alpha variant. After treatment in patients with moderate or severe severity, most lymphocyte subset counts were increased except the NK cells. Lower total lymphocyte counts, especially total T lymphocyte counts were associated with a higher occurrence of severe COVID-19.

CONCLUSION

The peripheral lymphocyte subset counts decreased according to disease severity and the types of SARS-CoV-2 variants in hospitalized COVID-19 patients. Despite the efficient operation of the national quarantine system and high vaccination rates in South Korea, it suggests that viral mutations evolve in a direction that further weakens the immune system. This is the only study on the difference in peripheral lymphocyte subset counts according to COVID-19 severity and SARS-CoV-2 variants conducted in South Korea, and therefore our data could be used as an important reference for another pandemic situation in the future.

摘要

背景

关于2019冠状病毒病(COVID-19)免疫系统特征和淋巴细胞亚群计数的研究已经通过多种方式开展,然而,根据严重急性呼吸综合征冠状病毒2(SARS-CoV-2)各变体对淋巴细胞亚群计数差异的研究却很少见。由于每个国家的检疫系统不同,有必要在疫苗接种率高且正在实施全面国家检疫系统的韩国等地调查相关特征。本研究的目的是调查韩国COVID-19患者外周血淋巴细胞亚群计数根据疾病严重程度和SARS-CoV-2变体的差异。

方法

韩国天主教大学医学院恩平圣母医院共纳入148例住院COVID-19患者。采用实时定量聚合酶链反应确认SARS-CoV-2感染,并根据入院时的氧支持治疗类型将COVID-19严重程度分为三组(轻度、中度和重度)。进行实验室检查以评估炎症状态。对所有148例患者入院时以及65例中度或重度患者治疗后,使用流式细胞术分析外周淋巴细胞亚群计数。我们分析了根据COVID-19严重程度三组和三种SARS-CoV-2变体(野生型和α、δ和奥密克戎变体)外周淋巴细胞亚群计数的变化。

结果

入院时,总T细胞、CD4 + T细胞、CD8 + T细胞、自然杀伤(NK)细胞和NKT细胞计数下降,但B细胞根据严重程度无明显变化。δ和奥密克戎变体中的总T细胞、CD4 + T细胞、CD8 + T细胞和NK细胞明显减少,而野生型和α变体中则没有。中度或重度患者治疗后,除NK细胞外,大多数淋巴细胞亚群计数增加。较低的总淋巴细胞计数,尤其是总T淋巴细胞计数与严重COVID-19的较高发生率相关。

结论

住院COVID-19患者外周淋巴细胞亚群计数根据疾病严重程度和SARS-CoV-2变体类型而下降。尽管韩国国家检疫系统高效运行且疫苗接种率高,但这表明病毒突变朝着进一步削弱免疫系统的方向演变。这是韩国唯一一项关于根据COVID-19严重程度和SARS-CoV-2变体对外周淋巴细胞亚群计数差异的研究,因此我们的数据可作为未来应对另一场大流行情况的重要参考。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索